DESCRIPTIVE ANALYSIS OF THE CARFILZOMIB TOXICITY PROFILE IN PATIENTS WITH MULTIPLE MYELOMA. EXPERIENCE IN A THIRD LEVEL CENTER

被引:0
|
作者
Gutierrez Lopez de Ocariz, X. [1 ]
Cuellar Perez-Avila, C. [1 ]
Zamanillo Herreros, I [1 ]
Iniguez Garcia, R. [1 ]
Poza Santaella, M. [1 ]
Alonso Fernandez, R. [1 ]
Sanchez Pina, J. M. [1 ]
Gonzalez Medina, J. [1 ]
Buenaventura Buendia, B. [1 ]
De Nicolas Sol, R. [1 ]
Vera Guerrero, E. [1 ]
Hidalgo Soto, M. [1 ]
Lopez Munoz, N. [1 ]
Lahuerta Palacios, J. J. [1 ]
Martinez Lopez, J. [1 ]
机构
[1] Hosp Univ Octubre, Madrid, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PO-020
引用
收藏
页码:201 / 202
页数:2
相关论文
共 50 条
  • [1] DESCRIPTIVE ANALYSIS OF THE CARFILZOMIB EFFECTIVENESS PROFILE IN PATIENTS WITH MULITPLE MYELOMA. EXPERIENCE IN A THIRD LEVEL CENTER
    Cuellar Perez-Avila, C.
    Gutierrez Lopez de Ocariz, X.
    Poza Sanaella, M.
    Zamanillo Herero, I
    Iniguez Garcia, R.
    Alonso Fernandez, R.
    Sanchez Pina, J. M.
    Gonzalez Medina, J.
    Buendia Urena, B.
    De Nicolas Sol, R.
    Vera Guerrero, E.
    Hidalgo Soto, M.
    Lopez Munoz, N.
    Lahuerta Palacios, J. J.
    Martinez Lopez, J.
    HAEMATOLOGICA, 2019, 104 : 202 - 203
  • [2] Carfilzomib experience in relapsed/refractory multiple myeloma: a single-center experience
    Uysal, Ayse
    Akad Soyer, Nur
    Ozkan, Melda
    Sahin, Fahri
    Vural, Filiz
    Tobu, Mahmut
    Tombuloglu, Murat
    Saydam, Guray
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2018, 48 (01) : 80 - 83
  • [3] CARFILZOMIB TREATMENT IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: SINGLE CENTER EXPERIENCE
    Uysal, A.
    Ozkan, M. Comert
    Soyer, N. Akad
    Sahin, F.
    Vural, F.
    Tobu, M.
    Tombuloglu, M.
    Saydam, G.
    LEUKEMIA RESEARCH, 2016, 49 : S29 - S30
  • [4] REAL LIFE DATA FROM THE FIRST LINE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA: EXPERIENCE OF A THIRD LEVEL CENTER
    Sanchez-Raga, J. M.
    Perez-Montana, A.
    Beltran, N.
    Ros, T.
    Boyeras, B.
    Martorell, C.
    Gutierrez, A.
    Sampol, A.
    HAEMATOLOGICA, 2019, 104 : 194 - 194
  • [5] Prognostic factors in multiple myeloma.: A multivariate analysis of presenting features in 394 patients with multiple myeloma.
    Turesson, I
    Abildgaard, N
    Dahl, IM
    Holmberg, E
    Hjorth, M
    Nielsen, JL
    Oden, A
    Seidel, C
    Waage, A
    Westin, J
    Wislöff, F
    BLOOD, 1998, 92 (10) : 271B - 271B
  • [6] VALIDATION OF A HOME PROTOCOL FOR AUTOLOGOUS HEMATOPOIETIC PROGENITOR TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA. EXPERIENCE OF A CENTER
    Pomares Tomas, Saez
    Martinez Ariadna, Perez
    Marquez Carlos, Carretero
    Rodriguez Ester, Algar
    Morales Rafael, Hernani
    Juan Carlos, Hernandez Boluda
    Jose Luis, Pinana Sanchez
    Maria Luisa, Calabuig Munoz
    Roig Enric, Santacatalina
    Vercet Carlos, Solano
    HAEMATOLOGICA, 2021, 106 (10) : 267 - 268
  • [7] Efficacy and Toxicity Profile of Carfilzomib Based Regimens for Treatment of Multiple Myeloma, a Systematic Review
    Mushtaq, Adeela
    Latif, Azka
    Kapoor, Vikas
    Warraich, Faiza Hassan
    Warraich, Sami Ullah
    Iftikhar, Ahmad
    Tenneti, Pavan
    Zafar, Raahem Nayab
    Russ, Atlantis Dawn
    Abraham, Ivo
    McBride, Ali
    Anwer, Faiz
    BLOOD, 2017, 130
  • [8] Efficacy and toxicity profile of carfilzomib based regimens for treatment of multiple myeloma: A systematic review
    Mushtaq, Adeela
    Kapoor, Vikas
    Latif, Azka
    Iftikhar, Ahmad
    Zahid, Umar
    McBride, Ali
    Abraham, Ivo
    Bin Riaz, Irbaz
    Anwer, Faiz
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 125 : 1 - 11
  • [9] PATIENTS OF ADVANCED AGE WITH DIAGNOSIS OF MULTIPLE MYELOMA. EXPERIENCE IN A CENTRE
    Gonzalez Lucia, Lopez
    Perez Mercedes, Varela
    Vizcaya Alvaro, Lorenzo
    Fernandez Ruben, Vazquez
    Suarez Michael, Calvino
    Trabazo Emilia, Fontanes
    Rubira Esperanza, Lavilla
    Diaz Sara, Ferrero
    Freire Angeles, Cobas
    Maria Jose, Sanchez Sanchez
    Sampedro Jesus, Arias
    HAEMATOLOGICA, 2016, 101 : 310 - 311
  • [10] Influence of renal failure on the osteoprotegerin level in patients with multiple myeloma.
    Goranov, Stefcho
    Goranova-Marinova, Veselina
    Kumchev, Emil
    Pavlov, Pavel
    Tzvetkova, Todorka
    BLOOD, 2006, 108 (11) : 338B - 338B